tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Stock WebsitesTop Gainers/ Losers/ Active StocksDividend StocksChatGPT Stocks
ETFs
ETF CenterTop ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Crypto CenterBitcoin
Popular
Ethereum
Research Tools
Stock ScreenerETF Screener
Popular
Compare StocksCompare ETFsTrending StocksTechnical Analysis ScreenerPenny Stock ScreenerDaily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit CalculatorCompound Interest Calculator
New
Mortgage Calculator
New
Auto Loan Calculator
New
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Stock Websites
Top Gainers/ Losers/ Active Stocks
Dividend Stocks
ChatGPT Stocks
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Research Tools
Stock Screener
ETF Screener
Popular
Compare Stocks
Compare ETFs
Trending Stocks
Technical Analysis Screener
Penny Stock Screener
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compound Interest Calculator
New
Mortgage Calculator
New
Auto Loan Calculator
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Enterprise Solutions
Plans & Pricing
Education
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

KA Stock Latest News

Kineta to Present New Preclinical Data on Lead Anti-CD27 Agonist Antibody at AACR Special Conference on Tumor Immunology and Immunotherapy
Press ReleasesKineta to Present New Preclinical Data on Lead Anti-CD27 Agonist Antibody at AACR Special Conference on Tumor Immunology and Immunotherapy
3d ago
KA
Kineta Announces New Research Agreement to Evaluate VISTA Biomarker Expression
Press ReleasesKineta Announces New Research Agreement to Evaluate VISTA Biomarker Expression
10d ago
KA
Kineta enters research agreement with Fred Hutchinson Cancer Center
The FlyKineta enters research agreement with Fred Hutchinson Cancer Center
10d ago
KA
Kineta to Participate in Upcoming Investor Conferences
Press ReleasesKineta to Participate in Upcoming Investor Conferences
28d ago
KA
Kineta Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Press ReleasesKineta Reports Second Quarter 2023 Financial Results and Provides Corporate Update
2M ago
KA
Kineta reports Q2 EPS 4c vs. ($1.23) last year
The FlyKineta reports Q2 EPS 4c vs. ($1.23) last year
2M ago
KA
Kineta to Receive $5 Million Milestone Payment from Merck
Press ReleasesKineta to Receive $5 Million Milestone Payment from Merck
3M ago
KA
Kineta to Receive $5M milestone payment from Merck
The FlyKineta to Receive $5M milestone payment from Merck
3M ago
KA
MRK
Kineta Expands Board of Directors with Biotech Industry Leaders Kim Drapkin and Scott Dylla
Press ReleasesKineta Expands Board of Directors with Biotech Industry Leaders Kim Drapkin and Scott Dylla
3M ago
KA
One new option listing and eighteen option delistings on June 26th
The FlyOne new option listing and eighteen option delistings on June 26th
3M ago
KA
ANTE
Kineta Set to Join Russell Microcap® Index
Press ReleasesKineta Set to Join Russell Microcap® Index
4M ago
KA
Kineta to Present at Jefferies Healthcare Conference
Press ReleasesKineta to Present at Jefferies Healthcare Conference
4M ago
KA
Kineta Reports First Quarter 2023 Financial Results and Provides Corporate Update
Press ReleasesKineta Reports First Quarter 2023 Financial Results and Provides Corporate Update
5M ago
KA
Kineta initiated with a Buy at H.C. Wainwright
The FlyKineta initiated with a Buy at H.C. Wainwright
5M ago
KA
Kineta, Inc. Announces Closing of $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Press ReleasesKineta, Inc. Announces Closing of $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5M ago
KA
Kineta prices 1.43M shares at $4.21 in registered direct offering
The FlyKineta prices 1.43M shares at $4.21 in registered direct offering
5M ago
KA
Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Press ReleasesKineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5M ago
KA
Kineta provides new data on VISTA biomarker and KVA12123 Phase 1/2 data
The FlyKineta provides new data on VISTA biomarker and KVA12123 Phase 1/2 data
5M ago
KA
Kineta Unveils New VISTA Biomarker Data and KVA12123 Phase 1/2 Clinical Trial Update at AACR Annual Meeting 2023
Press ReleasesKineta Unveils New VISTA Biomarker Data and KVA12123 Phase 1/2 Clinical Trial Update at AACR Annual Meeting 2023
5M ago
KA
Kineta Announces First Patient Dosed in Phase 1/2 Clinical Study of KVA12123 for Advanced Solid Tumors
Press ReleasesKineta Announces First Patient Dosed in Phase 1/2 Clinical Study of KVA12123 for Advanced Solid Tumors
6M ago
KA
Kineta: First patient dosed in Phase 1/2 clinical study of KVA12123
The FlyKineta: First patient dosed in Phase 1/2 clinical study of KVA12123
6M ago
KA
Kineta to Present at 22nd Annual Needham Healthcare Conference
Press ReleasesKineta to Present at 22nd Annual Needham Healthcare Conference
6M ago
KA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >